The E1B-55K protein plays an important role during human adenovirus type 5
productive infection, In the early phase of the viral infection, E1B-55K bi
nds to and inactivates the tumor suppressor protein p53, allowing efficient
replication of the virus. During the late phase of infection, E1B-55K is r
equired for efficient nucleocytoplasmic transport and translation of late v
iral mRNAs, as well as for host cell shutoff, In an effort to separate the
p53 binding and inactivation function and the late functions of the E1B-55K
protein, we have generated 26 single-amino-acid mutations in the E1B-55K p
rotein. These mutants were characterized for their ability to modulate the
p53 level, interact with the E4orf6 protein, mediate viral late-gene expres
sion, and support virus replication in human cancer cells, Of the 26 mutant
s, 24 can mediate p53 degradation as efficiently as the wild-type protein,
Two mutants, R240A (ONYX-051) and H260A (ONYX-053), failed to degrade p53 i
n the infected cells, In vitro binding assays indicated that R240A and H260
A bound p53 poorly compared to the wild-type protein,When interaction with
another viral protein, E4orf6, was examined, H260A significantly lost its a
bility to bind E4orf6, while R240A was fully functional in this interaction
. Another mutant, T255A, lost the ability to bind E4orf6, but unexpectedly,
viral late-gene expression was not affected. This raised the possibility t
hat the interaction between E1B-55K and E4orf6 was not required for efficie
nt viral mRNA transport, Both R240A and H260A have retained, at least parti
ally, the late functions of wild-type E1B-55K, as determined by the express
ion of viral late proteins, host cell shutoff, and lack of a cold-sensitive
phenotype, Virus expressing R240A (ONYX-051) replicated very efficiently i
n human cancer cells, while virus expressing H260A (ONYX-053) was attenuate
d compared to wild-type virus dl309 but was more active than ONYX-015, The
ability to separate the p53-inactivation activity and the late functions of
E1B-55K raises the possibility of generating adenovirus variants that reta
in the tumor selectivity of ONYX-015 but can replicate more efficiently tha
n ONYX-015 in a broad spectrum of cell types.